These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 3460811

  • 1. Changes in granulocyte-monocyte colony-forming cells among leukocyte-interferon-treated chronic myelogenous leukemia patients.
    Talpaz M, Spitzer G, Hittelman W, Kantarjian H, Gutterman J.
    Exp Hematol; 1986 Aug; 14(7):668-71. PubMed ID: 3460811
    [Abstract] [Full Text] [Related]

  • 2. Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cells.
    Beran M, O'Brien S, Andersson B, McCredie KB, Gutterman JU.
    Hematol Pathol; 1988 Aug; 2(2):65-71. PubMed ID: 3143710
    [Abstract] [Full Text] [Related]

  • 3. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G.
    Haematologica; 1997 Aug; 82(3):291-6. PubMed ID: 9234574
    [Abstract] [Full Text] [Related]

  • 4. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
    Betticher DC, Huxol H, Müller R, Speck B, Nissen C.
    Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
    [Abstract] [Full Text] [Related]

  • 5. Interferon-alpha alters the distribution of CFU-GM between the adherent and nonadherent compartments in long-term cultures of chronic myeloid leukemia marrow.
    Osterholz J, Dowding C, Guo AP, Siczkowski M, Goldman JM.
    Exp Hematol; 1991 Jun; 19(5):326-31. PubMed ID: 2026184
    [Abstract] [Full Text] [Related]

  • 6. Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM.
    Gordon MY, Marley SB, Lewis JL, Davidson RJ, Nguyen DX, Grand FH, Amos TA, Goldman JM.
    J Clin Invest; 1998 Aug 15; 102(4):710-5. PubMed ID: 9710439
    [Abstract] [Full Text] [Related]

  • 7. Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia.
    Talpaz M, Kantarjian HM, McCredie K, Trujillo JM, Keating MJ, Gutterman JU.
    N Engl J Med; 1986 Apr 24; 314(17):1065-9. PubMed ID: 3457264
    [Abstract] [Full Text] [Related]

  • 8. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
    Després D, Goldschmitt J, Aulitzky WE, Huber C, Peschel C.
    Exp Hematol; 1995 Dec 24; 23(14):1431-8. PubMed ID: 8542928
    [Abstract] [Full Text] [Related]

  • 9. Evidence for the presence in sera from chronic myelogenous leukemia patients of an activity that enhances the number of normal bone marrow-derived granulocyte/monocyte committed stem cell colonies.
    Rao SG, Kothari V, Nadkarni K, Ahuja H, Advani S.
    Nouv Rev Fr Hematol (1978); 1987 Dec 24; 29(4):231-6. PubMed ID: 3501108
    [Abstract] [Full Text] [Related]

  • 10. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM, Chimirri F, Podestà M, Pitto A, Piaggio G, Dejana A, Lerma E, Pollicardo N, Vassallo F, Soracco M, Benvenuto F, Valbonesi M, Carlier P, Vimercati R, Prencipe E, Gatti AM, Ferrara RA, Incagliato M, Florio G, Frassoni F.
    Bone Marrow Transplant; 1996 Feb 24; 17(2):201-5. PubMed ID: 8640167
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
    Crump M, Couture F, Kovacs M, Saragosa R, McCrae J, Brandwein J, Huebsch L, Beauregard-Zollinger L, Keating A.
    Exp Hematol; 1993 Mar 24; 21(3):405-410. PubMed ID: 8440338
    [Abstract] [Full Text] [Related]

  • 12. Differential responses of fetal, neonatal, and adult myelopoietic progenitors to interferon and tumor necrosis factor.
    Hahn T, Shulman LM, Ben-Hur H, Karov Y, Barak V, Handgretinger R, Barak Y.
    Exp Hematol; 1994 Feb 24; 22(2):114-21. PubMed ID: 8299733
    [Abstract] [Full Text] [Related]

  • 13. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
    Posthuma EF, Marijt EW, Barge RM, van Soest RA, Baas IO, Starrenburg CW, van Zelderen-Bhola SL, Fibbe WE, Smit WM, Willemze R, Falkenburg JH.
    Biol Blood Marrow Transplant; 2004 Mar 24; 10(3):204-12. PubMed ID: 14993886
    [Abstract] [Full Text] [Related]

  • 14. [In vitro inducing differentiation of bone marrow mononuclear cells of chronic myeloid leukemia].
    Wu CY, Zhang LS, Zhang YF, Chai Y, Yi LC, Song FX.
    Ai Zheng; 2005 Apr 24; 24(4):425-31. PubMed ID: 15820064
    [Abstract] [Full Text] [Related]

  • 15. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
    Einat M, Lishner M, Amiel A, Nagler A, Yarkorli S, Rudi A, Kashman Y, Markel D, Fabian I.
    Exp Hematol; 1995 Dec 24; 23(14):1439-44. PubMed ID: 8542929
    [Abstract] [Full Text] [Related]

  • 16. Discordant maturation as the primary biological defect in chronic myelogenous leukemia.
    Strife A, Lambek C, Wisniewski D, Wachter M, Gulati SC, Clarkson BD.
    Cancer Res; 1988 Feb 15; 48(4):1035-41. PubMed ID: 3422181
    [Abstract] [Full Text] [Related]

  • 17. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM, Fortuna A, Fogli M, Gherlinzoni F, Rosti G, Catani L, Gozzetti A, Miggiano MC, Tura S.
    Exp Hematol; 1995 Dec 15; 23(14):1520-6. PubMed ID: 8542941
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Collection of Ph-negative progenitor cells from interferon responsive patients with chronic myeloid leukemia: effect of granulocyte-colony-stimulating factor mobilization.
    Olavarria E, Parker S, Craddock C, Philpott N, Tiniakou M, Chase A, Kanfer E, Apperley JF, Goldman JM.
    Haematologica; 2000 Jun 15; 85(6):647-52. PubMed ID: 10870123
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.